Evoke Wealth’s STAAR Surgical STAA Stock Holding History

Evoke Wealth’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-191	Closed	-$6.72K	–	1326
2019 Q4	$6.72K	Buy	191 +21	+12%	+$693	﹤0.01%	847
2019 Q3	$4.38K	Buy	+170	New	+$5.17K	﹤0.01%	1038

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Evoke Wealth's STAA Position: Q1 2020 in Review

Evoke Wealth sold out of STAAR Surgical (STAA) in Q1 2020, closing a stake of 191 shares — an estimated $6.72K sold.

Evoke Wealth first reported a position in STAA in Q3 2019 and held it in 2 quarters. The position peaked at $6.72K in Q4 2019. 160 funds tracked by Wall St. Rank hold STAA as of Q1 2020.

Evoke Wealth reported no remaining STAAR Surgical position as of Q1 2020 after selling out during the quarter.
Evoke Wealth sold 191 STAAR Surgical shares in Q1 2020, an estimated $6.72K.
Evoke Wealth first reported a position in STAAR Surgical in Q3 2019 and held it in 2 quarters.
Evoke Wealth's STAAR Surgical position peaked at $6.72K in Q4 2019.
160 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2020.

Based on Evoke Wealth's 13F filing for Q1 2020, filed 7 May 2020.